According to a recent LinkedIn post from Phantom Neuro, the company plans to participate in The Montgomery Summit 2026 in Santa Monica, CA, where Founder and CEO Connor Glass is slated to present its Phantom X neural interface. The post describes Phantom X as a minimally invasive system placed beneath the skin to decode muscle signals and, using artificial intelligence, enable intuitive control of prosthetic limbs.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post indicates that the presentation will emphasize high-accuracy, low-latency decoding of hand and wrist movements in real time, positioning the technology as a potential improvement over existing, more cumbersome prosthesis control methods. For investors, this conference appearance may serve as a visibility and validation event, potentially attracting interest from healthcare, biotech, and neurotech investors as Phantom Neuro seeks to advance its role in human–machine interaction and AI-enabled medical devices.